UKRI Translation: BBSRC Proof of Concept 2026 supports researchers turning bioscience discoveries into products, services and solutions to deliver economic, societal or environmental benefits to the UK.
UKRI Translation: MRC Proof of Concept: stage one supports academic teams developing and testing medical interventions and research tools to address significant health needs and advance patient benefit.
UKRI translation: MRC proof of concept: stage two supports academic teams developing and testing medical interventions from prototypes through early clinical trials to advance patient benefit or commercialisation.
BBSRC-STFC DeepTech Catalyst Bio 2026 supports early-stage biotechnology start-ups with R&D funding, specialist advice and campus access to advance bioscience innovations towards commercialisation.
Supports arts and humanities researchers in turning previous AHRC or UKRI-funded projects into real-world impact through innovative knowledge exchange, commercialisation, and partnerships.
Engineering Biology Investor Partnerships round 1 supports UK SMEs with grants and aligned private investment to develop close-to-market engineering biology products and services for commercialisation.